Journal of Neuro-Oncology

, Volume 137, Issue 2, pp 379–385 | Cite as

To drive or not to drive, that is still the question: current challenges in driving recommendations for patients with brain tumours

  • Ann Mansur
  • Alexa Desimone
  • Sara Vaughan
  • Tom A. Schweizer
  • Sunit Das
Clinical Study


Driving is a complex task that requires integration of various skills that may be impaired in patients with brain tumours. Determining fitness to drive is a responsibility of all physicians in Canada; however, it is an inconsistent practice based on few objective guidelines. The primary purpose of the study is to determine the consistency of driving recommendations amongst health care professionals in Ontario. Secondary aims include evaluation of physician awareness of driving regulations and determination of whether physicians would benefit from more specific driving guidelines. An 18-item questionnaire was sent to 126 health care professionals who take care of patients with brain tumours in Ontario. Seventy-five health care professionals responded to the survey. Less than 10% said they could reliably determine fitness to drive and almost an equal percentage of respondents indicated that determining fitness to drive should be a shared responsibility. The factors deemed important in determining driving safety were highly variable; 70% indicated that cognitive and emotional deficits were important. Over a third of respondents never heard of the CMA guidelines and of those who were familiar with it, 12.5% felt they were sufficient to inform clinical decisions. 90% of respondents wanted more specific and detailed driving guidelines for patients with brain tumours. The current guidelines for physicians are not specific enough for physicians to confidently determine fitness to drive in this population. These findings suggest the need for more detailed guidelines for driving safety that are based on empirical studies on driving habits and performance in patients with a variety of brain tumours.


Brain tumour Neuro-oncology Driving Guidelines 



St. Michael’s Brain Tumour Research Fund and the Comprehensive Research Experience for Medical Students (CREMS).

Compliance with ethical standards

Conflict of interest

None of the authors report any conflicts of interest.

Ethical approval

This study was approved by the local institutional review board.

Informed consent

All participants provided written informed consent.

Supplementary material

11060_2017_2727_MOESM1_ESM.doc (85 kb)
Supplementary material 1 (DOC 85 KB)


  1. 1.
    North American Brain Tumour Coalition: know the facts (2009) Available but inactiveGoogle Scholar
  2. 2.
    Central Brain Tumor Registry of the United States (2016) 2016 CBTRUS Fact Sheet.
  3. 3.
    Canadian Medical Association (CMA) (2006) Determining Medical Fitness to Operate Motor Vehicles. CMA Driver’s Guide. 7th edn. OttawaGoogle Scholar
  4. 4.
    American Medical Association and the National Highway Traffic Safety Administration (2010) Physician’s guide to assessing and counselling older drivers 2nd edn.Google Scholar
  5. 5.
    Driver and Vehicle Licensing Agency (2017) Assessing fitness to drive—a guide for medical professionals. sionals-conditions-s-to-u
  6. 6.
    Austroads and the National Transport Commission (2016) Assessing fitness to drive for commercial and private vehicle drivers: medical standards for licensing and clinical management guidelines. SydneyGoogle Scholar
  7. 7.
    Government of Ontario (1990) Highway Traffic Act, R.S.O. 1990, c.H.8, s.203(1)Google Scholar
  8. 8.
    Louie AV, D’Souza DP, Palma DA et al (2012) Fitness to drive in patients with brain tumours: the influence of mandatory reporting legislation on radiation oncologists in Canada. Curr Oncol 19:117–122CrossRefGoogle Scholar
  9. 9.
    Louie AV, Chan E, Hanna M et al (2013) Assessing fitness to drive in brain tumour patients: a grey matter of law, ethics and medicine. Curr Oncol 20:90–96CrossRefGoogle Scholar
  10. 10.
    Chan E, Louie AV, Hanna M et al (2013) Multisciplinary assessment of fitness to drive in brain tumour patients in southwestern Ontario: a grey matter. Curr Oncol 20:4–12Google Scholar
  11. 11.
    Thomas S, Mehta MP, Kuo JS et al (2011) Current practices of driving restriction implementation for patients with brain tumours. J Neurooncol 103:641–647CrossRefGoogle Scholar
  12. 12.
    Black L (2008) Physicians’ legal responsibility to report impaired drivers. Virtual Mentor 10(6):393–396CrossRefGoogle Scholar
  13. 13.
    Chin YS, Jayamohan J, Clouston P et al (2004) Driving and patients with brain tumours: a postal survey of neurosurgeons, neurologists and radiation oncologists. J Clin Neurosci 11(5):471–474CrossRefGoogle Scholar
  14. 14.
    McDonald KL (2011) Brain tumours and driving. J Neurooncol 104:399–400CrossRefGoogle Scholar
  15. 15.
  16. 16.
    Yuen HK, Sharma AK, Logan WC et al (2008) Radiation dose, driving performance, and cognitive function in patients with head and neck cancer. Radiother Oncol 87:304–307CrossRefGoogle Scholar
  17. 17.
    Yuen HK, Gillespie MB, Barkley RA et al (2007) Driving performance in patients with cancer in the head and neck region: a pilot study. Arch Otalaryngol Head Neck Surg 133:904–909CrossRefGoogle Scholar
  18. 18.
    Yuen HK, Gillespie MB, Day TA et al (2007) Driving behaviours in patients with head and neck cancer during and after cancer treatment: a preliminary report. Head Neck 29:675–681CrossRefGoogle Scholar
  19. 19.
    Weir N, Fischer A, Good P (2017) Assessing the practice of palliative care doctors: what driving advice do they give patients with advanced disease? Intern Med J 47:1161–1165CrossRefGoogle Scholar
  20. 20.
    Strand MC, Fjeld B, Arnestad M, Morland J (2013) Can patients receiving opioid maintenance therapy safely drive? A systematic review of epidemiological and experimental studies on driving ability with a focus on concomitant methadone or buprenorphine administration. Traffic Inj Prev 14:26–38CrossRefGoogle Scholar
  21. 21.
    Monarrez-Espino J, Laflamme L, Rausch C et al (2016) New opioid analgesic use and the risk of injurious single-vehicle crashes in drivers aged 50–80 years: a population-based matched case-control study. Age Ageing 45:628–634CrossRefGoogle Scholar
  22. 22.
    Verster JC, Veldhuijzen DS, Volkerts ER (2006) Effects of an opioid (oxycodone/paracetamol) and an NSAID (bromfenac) on driving ability, memory functioning, psychomotor performance, pupil size, and mood. Clin J Pain 22:499–504CrossRefGoogle Scholar
  23. 23.
    Triebel KL, Martin RC, Nabors LB, Marson DC (2009) Medical decision-making capacity in patients with malignant glioma. Neurology 73:2086–2092CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  1. 1.University of Toronto Faculty of MedicineTorontoCanada
  2. 2.Li Ka Shing Knowledge InstituteSt. Michael’s HospitalTorontoCanada
  3. 3.Institute of Biomaterials and Biomedical EngineeringUniversity of TorontoTorontoCanada
  4. 4.Division of NeurosurgerySt. Michael’s HospitalTorontoCanada

Personalised recommendations